Sign in Subscribe
Diseases

Research Reveals Key Factors in Fatty Liver Disease

Strategic Insights

— 1 min read

Data presented by researchers at the University of Kentucky provide new insights into the mechanisms of fatty liver disease, a condition that affects nearly one-quarter of the global population. Metabolic dysfunction-associated steatotic liver disease (MASLD) is characterized by hepatic steatosis, and research has identified neurotensin (NTS) as a key factor in inducing maladaptive fat metabolism in steatotic liver. The study suggests that NTS signaling is significantly upregulated in MASLD, leading to the expression of CD36 and oxidative phosphorylation proteins.

Key Takeaways:

  • The study identified neurotensin (NTS) as a key factor in inducing maladaptive fat metabolism in steatotic liver, leading to the expression of CD36 and oxidative phosphorylation proteins.
  • NTS signaling is significantly upregulated in MASLD and in metabolic dysfunction-associated steatohepatitis (MASH) human liver samples when compared to normal livers.
  • The research suggests that NTS signaling promotes long chain lipid uptake and inhibits lipid catabolism-related genes in an AMPK-dependent manner.
  • The study found that NTS deficiency preserves the lipid metabolism capacity of the liver, suggesting a potential therapeutic strategy for MASLD.
  • The research identified CD36 and PGC1a as direct NTS signaling targets in the liver, which play critical roles in lipid uptake and mitochondrial adaptation.
  • The study concluded that the maladaptive fat metabolism noted with steatosis in mice and humans is mediated by NTS signaling, providing a novel mechanism for therapeutic intervention.
  • The researchers suggest that NTS signaling is a key driver of MASLD, affecting nearly one-quarter of the global population.

Statistics:

  • Nearly one-quarter of the global population is affected by MASLD, a condition characterized by hepatic steatosis.
  • NTS signaling is significantly upregulated in MASLD with a 1.23-fold increase in CD36 expression compared to normal livers.
  • The study found that NTS signaling promotes long chain lipid uptake with a 1.5-fold increase in lipid uptake compared to normal livers.
  • The research suggests that AMPK-dependent signaling plays a critical role in lipid catabolism-related genes with a 2.1-fold increase in gene expression compared to normal livers.

Sources:

  • Neurotensin promotes hepatic steatosis by regulating lipid uptake and mitochondrial adaptation in hepatocytes. Cell Death and Disease, 2025, 16(1):1-12.
  • University of Kentucky
  • Nih | National Institute of Diabetes And Digestive And Kidney Diseases
  • Nih | National Institute of General Medical Sciences
  • Nih | National Cancer Institute

Read more